iiinova — where your digital self keeps evolving

Reposted by Alberto Garcia-Basteiro

Rebecca Clark @raclark18.bsky.social · 15/06/2026

Thanks to all the coauthors involved in this work Mark Hatherill Leonardo Martinez Andrew Fiore-Gartland @agbasteiro.bsky.social Gavin Churchyard Molebogeng X Rangaka @mbehr-mcgill.bsky.social Thomas Evans Vidya Mave Philip C Hill Willem Hanekom Frank Cobelens @richardwhite321.bsky.social

121

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 22/12/2025

Happy festive season to everyone! Thank you to all our partners, funders and collaborators for an excellent 2025! 💛💚💛💚 @mtbi.bsky.social @isglobal.bsky.social @hospitalclinic.bsky.social @medicinacs-ub.bsky.social

020

Reposted by Alberto Garcia-Basteiro

ISGlobal @isglobal.org · 03/12/2025

👏 ¡El investigador de #ISGlobal Alberto García-Basteiro (@agbasteiro.bsky.social) se ha incorporado como nuevo miembro de la Academia Joven de España! 🌍 Un reconocimiento que pone en valor su trayectoria científica y su compromiso con la generación de conocimiento para mejorar la #SaludGlobal.

051

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 22/11/2025

Fantastic @theunion.org meeting in #Copenhagen. It is always great to catch up with so many friends and colleagues from all over the world. #the #fight #against #tuberculosis @mtbi.bsky.social @isglobal.bsky.social

061

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 12/11/2025

During World Science Day for Peace and Development, Dr. Dinis Nguenha from CISM shared that using the #Truenat portable molecular diagnostic system enabled 82% of TB patients to start treatment on the same day of diagnosis, improving care and reducing delays!

031

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 11/11/2025

🗨️ Our PhD student, Salome Valencia, presented today at the XXIX Jornadas Internacionales sobre Tuberculosis 2025, hosted by #CoMB, #uiTB & #fuiTB. She explored how armed conflict and social inequality shape #TB in Colombia. Grateful to all for fostering these vital discussions!

021

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 11/11/2025

👏 Dr. Belén Saavedra Cervera (ISGlobal & CISM) wowed audiences at the XXIX Jornadas sobre Tuberculosis 2025, presenting key findings on TB transmission in Manhiça through molecular epidemiology. Thanks to #CoMB, #uiTB & #fuiTB!

041

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 05/09/2025

🚨 Exciting global health opportunity! @isglobal.org is hiring a Medical Research Fellow (Tuberculosis) in Manhiça, Mozambique. Lead impactful TB research with a top team. 🩺 MD + 4yrs clinical exp 🗓️ 2-yr contract 🔗 Apply: jobs.isglobal.org/jobs/6376227 #GlobalHealth #TB #ResearchJobs #PublicHealth

jobs.isglobal.org

Medical Research Fellow, Area of Tuberculosis - Barcelona Institute for Global Health (ISGlobal)

The Barcelona Institute for Global Health (ISGlobal) is a cutting-edge institute addressing global public health challenges through research, translation into policy and education. ISGlobal has a b...

042

Reposted by Alberto Garcia-Basteiro

Katherine Horton @kchorton.bsky.social · 04/07/2025

In our latest personal view in @lancetrespirmed.bsky.social, we argue for the inclusion asymptomatic #tuberculosis in vaccine trial endpoints to potentially reduce the size, length, and cost of trials. doi.org/10.1016/S221... @lshtm-tbmod.bsky.social @tb-lshtm.bsky.social

Figure 1. Estimated number of trial endpoints in the control group of a prevention-of-disease vaccine trial in a high disease-burden setting showing number of endpoints on the y-axis and time in months on the x-axis. For bacteriologically confirmed symptomatic tuberculosis disease endpoints only, we estimate 69 endpoints, and for combined bacteriologically confirmed asymptomatic and symptomatic tuberculosis disease endpoints, we estimate 151 endpoints. Scenario assumes symptomatic disease incidence before trial screening of 300/100 000 per year and following 10 000 individuals over 3 years. Prevalent symptomatic and asymptomatic tuberculosis disease are screened out in month 0 and are not trial endpoints. Active screening occurs every 6 months for both scenarios and participants self-presenting with symptoms suggestive of tuberculosis disease would also be investigated.

31414

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 03/07/2025

💥Today we share great news! @agbasteiro.bsky.social has been honored with the XX Banc Sabadell Foundation Award for Biomedical Research! 👏🏾 🔗 fundacionbancosabadell.com/la-fundacion... #PremiosBiomédicaCiencias #LaCulturadelTalento #Investigación

fundacionbancosabadell.com

La Fundación Banco Sabadell premia dos investigadores por sus trabajos sobre la tuberculosis y sobre el diseño computacional de enzimas - Fundación Banco Sabadell

022

Reposted by Alberto Garcia-Basteiro

ISGlobal @isglobal.org · 01/07/2025

Deben participar las personas encarceladas en ensayos de vacunas contra la #TB? "Hay que garantizar ensayos seguros y éticos para una vacuna que podría proteger su salud y la de sus familias", dice @agbasteiro.bsky.social. #EndTB

f.mtr.cool

Ensayos de vacunas en prisiones - ISGLOBAL

Sobre el derecho de las personas privadas de libertad a participar en investigaciones biomédicas, siempre que se respete su autonomía y sus derechos

011

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 30/06/2025

We just published a piece about the participation of people deprived of liberty in #tuberculosis vaccine trials. Should they be protected from research, or through research? www.thelancet.com/journals/lan... @thelancetinfdis.bsky.social @isglobal.org @mtbi.bsky.social

1115

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 26/06/2025

#MTBI was proud to join the 12th #EDCTP Forum last week in Kigali, Rwanda. The event brought together global leaders to advance clinical research and partnerships in sub-Saharan Africa. A great opportunity to connect, share insights, and support better health through global collaboration.

121

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 19/06/2025

I am grateful for the opportunity to present at the #EDCTPforum in Kigali. We had a great session on #Tuberculosis prediction and early TB trajectories, with Shima Abdulgader and Edson Marambire. Chaired by @kkranzer.bsky.social & @willyssengooba.bsky.social

091

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 15/06/2025

Great opening ceremony of the #EDCTPforum in Kigali, Rwanda 🇷🇼 Excited to be here and meet many colleagues and friends. Presenting this upcoming Tuesday on the science of #tuberculosis prediction @isglobal.org @mtbi.bsky.social @ub.edu

050

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 06/06/2025

#MTBI members Dr. Lucía Carratalá & @joannaehrlich.bsky.social ‪joined other colleagues to present updates on the final key study results, main indicators & data management. 👏A great opportunity to showcase the hard work behind Impactful research on the advances in TB diagnostics. #endTB #Stool4TB

011

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 06/06/2025

The #Stool4TB Consortium Annual Meeting in Eswatini kicked off with opening remarks from Dr. @agbasteiro.bsky.social, PI of the #MTBI initiative, and Ms. Rejoice Nkambule, Deputy Director of Public Health at Eswatini’s Ministry of Health.

111

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 04/06/2025

This achievement highlights the power of collaboration, innovation, and commitment to advancing global health. #Stool4TB focuses on validating a qPCR stool-based test designed to improve TB diagnosis in children and people living with HIV. 🔗 Learn more: www.stool4tb.org

stool4tb.org

(Stool4TB)

011

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 04/06/2025

✨The final annual meeting of the #Stool4TB Consortium in Mbabane, Eswatini, was a great success — marking the conclusion of five years of collaborative research to improve tuberculosis diagnosis. Partners from across Eswatini, Uganda, and Mozambique came together to celebrate a major milestone!

111

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 23/05/2025

Today @prados-rosales.bsky.social came to visit us. His presentation on extracellular vesicles for #TB diagnosis was extremely interesting and engaging. Come back soon Rafa!! @mtbi.bsky.social @isglobal.org

000

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 19/05/2025

🟡 We're pleased to be participating in the TBnet Academy in Tirana this week! 📸 Today, Dr. @agbasteiro.bsky.social delivered a talk on Asymptomatic Tuberculosis, sharing insights on one of the most challenging aspects of TB control. #TBnetAcademy #endTB #MTBI

011

Reposted by Alberto Garcia-Basteiro

ISGlobal @isglobal.org · 14/05/2025

Alberto García-Basteiro (@agbasteiro.bsky.social) has been recognised as a “Fellow” by the European Respiratory Society — one of the highest honours in the field of respiratory medicine. 👏 Congratulations, Alberto! 🟠 www.isglobal.org/en/-/alberto...

042

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 22/04/2025

I am happy to share this piece about "Transforming partnerships through transboundary research" published in BMJ Global Health. It addresses the structural asymmetries that continue to affect collaborations in global health @isglobal.bsky.social @mtbi.bsky.social gh.bmj.com/content/bmjg...

042

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 27/03/2025

👏🏾 El debate de ayer de #CaixaResearch sobre #Tuberculosis fue imprescindible. La enfermedad infecciosa más mortal del mundo fue analizada en profundidad por @agbasteiro.bsky.social, @pjcardona14.bsky.social e Iñaki Comas. ➡️ Si te lo perdiste, aún puedes verlo: www.youtube.com/watch?v=USQv...

133

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 26/03/2025

❗Hoy participamos en un debate de Caixa Research sobre #TB. Estará uno de nuestros PI @agbasteiro.bsky.social, junto con @pjcardona14.bsky.social e Iñaki Comas, con la moderadora Jessica Mouzo. ¡No os lo perdáis! Apúntate: caixaresearch.org/es/debates-c... #endTB #MTBI #CaixaResearch

042

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 24/03/2025

💥 Today we are reminded that TB is one of the deadliest infectious diseases worldwide. Despite being preventable and curable, millions of people still suffer from its effects. MTBI is committed to improving TB diagnosis, treatment, and prevention to move closer to its eradication. #endTB #WorldTBDay

113

Reposted by Alberto Garcia-Basteiro

ISGlobal @isglobal.org · 24/03/2025

🫁 #Tuberculosis has once again become the deadliest infectious disease worldwide. Up to 68% of transmission can come from asymptomatic people. On #WorldTBDay, we shine a light on these silent infections: 🟠 www.isglobal.org/en/healthisg... @agbasteiro.bsky.social @joannaehrlich.bsky.social

025

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 21/03/2025

Orgulloso del Dr Guillermo Sequera, (re)presentando los resultados de su tesis, “Dinámicas epidemiológicas de la TB entre las prisiones y la comunidad en Paraguay”. premiada hoy x la @tb-uitb.bsky.social (con otras 2) como mejor tesis en Tuberculosis de 2024 @isglobal.bsky.social @mtbi.bsky.social

251

Reposted by Alberto Garcia-Basteiro

Samuel G. Schumacher @sgschumacher.bsky.social · 19/03/2025

Last year we released WHO Guidance on evidence generation (GEG) on new regimens for #TB treatment — a first-of-its-kind document that provides advise on how evidence should be generated to optimally inform WHO guideline development: bsky.app/profile/sgsc... www.who.int/publications...

185

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 10/03/2025

El próximo 26 de marzo, no os perdáis el debate de Caixa Research sobre #TB en el que participará uno de nuestro PI @agbasteiro.bsky.social, junto con @pjcardona14.bsky.social e Iñaki Comas, con la moderadora Jessica Mouzo. Apúntate: caixaresearch.org/es/debates-c... #endTB #MTBI #CaixaResearch

043

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 12/03/2025

🔬 #MTBI never stop learning to improve and continue growing as a team. Yesterday, some of our members participated in the Electrocardiography Update and Improvement Course, led by Dr. Neusa Jessen, which provided comprehensive insights into conducting and interpreting ECGs 👏

031

Reposted by Alberto Garcia-Basteiro

PTI+ Salud Global @ptisg.bsky.social · 07/03/2025

El miércoles 26 de marzo podéis seguir el debate "La tuberculosis sigue siendo la enfermedad infecciosa que más muertes causa". Con los ponentes Iñaki Comas, Alberto García-Basteiro (@agbasteiro.bsky.social) y Pere-Joan Cardona. tinyurl.com/59429djw

tinyurl.com

DEBATES CaixaResearch - Investigación en tuberculosis

Investigadores expertos debaten sobre los avances en la investigación de la tuberculosis en los DEBATES CaixaResearch de la Fundación ”la Caixa”.

011

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 04/03/2025

The PreFIT Consortium Annual Meeting continues! 🔬🚀 Today’s sessions covered key aspects of communication, dissemination, and exploitation, as well as scientific output and updates on PRESTO and collaborative studies. 📸 Some presentations were lead by #MTBI members @agbasteiro.bsky.social and @Dinis

121

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 04/03/2025

It has been a fantastic #PreFIT meeting. Thank you to Prof Grant Theron @suhealthsci.bsky.social for hosting us and showing us the world class facilities at BMRI @isglobal.org @mtbi.bsky.social

010

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 17/02/2025

🔬✨ @clarasuner.bsky.social investigadora de #MTBI fue a visitar a los estudiantes del Institut El Cairat, para compartir cómo es el día a día de una científica e inspirar a los más jóvenes, que participaron en un experimento simulador de ensayo clínico. #MTBI #FuturoDeLaCiencia #científiques

112

Reposted by Alberto Garcia-Basteiro

WHO @who.int · 17/02/2025

#Measles is one of the leading causes of death among young children globally. In 2023, an estimated 107 500 people died from measles, mostly children under age 5. bit.ly/48SAtkf

17638245

Reposted by Alberto Garcia-Basteiro

Madhu Pai, MD, PhD @madhupai.bsky.social · 13/02/2025

With its anti-science and anti-public health policies, the US is now at risk for outbreaks of tuberculosis As @johngreensbluesky.bsky.social put it, "TB is both a form and expression of injustice" www.thelancet.com/journals/lan...

38339

Reposted by Alberto Garcia-Basteiro

The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 13/02/2025

🗞️News 📰Historic #TB outbreak a wake-up call for US policy makers Written by @bryantfurlow.bsky.social tinyurl.com/8u6nmf4a #EndTB #TBsky #tuberculosis @theunion-tblh.bsky.social

Image shows a quote from the piece on how the Kansas outbreak should be a wake up call for what can happen when we divert resources away from public health

089

Reposted by Alberto Garcia-Basteiro

Catherine Berry (she/her) @catherineberry.bsky.social · 09/02/2025

This looks great. 🔥👇🏻 #TBsky

282

Reposted by Alberto Garcia-Basteiro

Adam R Houston @healthlawadamh.bsky.social · 10/02/2025

Looks like Canada's #tuberculosis stats for 2023 were quietly released. 2217 cases. www.canada.ca/content/dam/... First time breaking 2000 cases since 1994. Highest number of cases since 1984.

Screenshot of the first chart in the attached link

24534

Reposted by Alberto Garcia-Basteiro

MTBI @mtbi.bsky.social · 07/02/2025

⭕️Given the intricate relationship between #TB, #HIV, and malnutrition, our findings provide valuable insights to enhance risk stratification and inform preventive strategies in high-burden settings. ➡️Full article: lnkd.in/dxA438pe

011

Alberto Garcia-Basteiro @agbasteiro.bsky.social · 06/02/2025

Interesting paper published today in Chest, led by Cheng Chen and Leo Martinez. High frequency of reversions observed when serial QTF is performed. Reversion rates decreased with time from exposure and at older ages. Data from 4 different countries @chest linkinghub.elsevier.com/retrieve/pii...

linkinghub.elsevier.com

Redirecting

021